Development of Matrix-Type Transdermal Delivery of Lornoxicam: In Vitro Evaluation and Pharmacodynamic and Pharmacokinetic Studies in Albino Rats

References

1. 1.↵
   1. Berba J.,
   2. Granson S.,
   3. Langle J.,
   4. Banakar, U. V

   . In vitro release of selected nonsteroidal anti-inflammatory analgesics from reservoir type transdermal formulations. Drug Dev. Ind. Pharm. 1991, 17 (1), 55–65.

   OpenUrl
2. 2.↵
   1. Beetge E.,
   2. Plessis J.,
   3. Muler, D. G.,
   4. Goosen C.,
   5. Rensburg, F. J

   . The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAIDs on their transdermal absorption. Int. J. Pharm. 2000, 193 (2), 261–264.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Codes G.,
   2. Fischer W.,
   3. Legler U.,
   4. Wolff, H. M

   . Proceedings of 3rd TTS Symposium; Tokyo, Japan, 1987; pp 3–8.
4. 4.↵
   1. Robinson J. R.,
   2. Lee V. H. L.

   1. Chien Y. W

   . Transdermal Therapeutic System. In Controlled Drug Delivery Fundamentals and applications. 2nd ed.; Robinson J. R., Lee V. H. L. Eds.; Marcel Dekker: New York, 1987; pp 524–552.
5. 5.↵
   1. Koskelaa, R. V.,
   2. Hirvonen J.,
   3. Monkkonen J.,
   4. Kiesvaara J.,
   5. Antila S.,
   6. Lehtonen L.,
   7. Urtti A

   . Transdermal delivery of levosimendan. Eur. J. Pharm. Sci. 2000, 11 (4), 343–350.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Guy, R. H.,
   2. Hadgraft J

   . Physicochemical aspects of percutaneous penetration and its enhancement. Pharm. Res. 1988, 5 (12), 753–758.

   OpenUrlPubMed
7. 7.↵
   1. Balfour, J. A.,
   2. Fitton A.,
   3. Barradell, L. B

   . Lornoxicam: A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996, 51 (4), 639–657.

   OpenUrlPubMedWeb of Science
8. 8.↵
   1. Skjodt, N. M.,
   2. Davies, N. M

   . Clinical pharmacokinetics of lornoxicam: A short half-life oxicam. Clin. Pharmacokinet. 1998, 34 (6), 421–428.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Baboota S.,
   2. Shakeel F.,
   3. Ahuja A.,
   4. Ali J.,
   5. Shaafiq S

   . Design development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm. 2007, 57 (3), 315–332.

   OpenUrlPubMed
10. 10.↵
    1. Escribano E.,
    2. Calpena, A. C.,
    3. Queralt J.,
    4. Obach R.,
    5. Domenech J

    . Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur. J. Pharm. Sci. 2003, 19 (4), 203–210.

    OpenUrlPubMed
11. 11.↵
    1. Aronson J. K

    . Meyler's Side Effects of Drugs: The International Encyclopedia of adverse drug reactions and Interactions; Elsevier: Amsterdam, The Netherlands, 2006; pp 2167–2168.
12. 12.↵
    1. Yakhno N.,
    2. Guekht A.,
    3. Skoromets A.,
    4. Spirin N.,
    5. Strachunskaya E.,
    6. Ternavsky A.,
    7. Olsen, K. J.,
    8. Moller, P. L

    . Analgesic efficacy and safety of lornoxicam quick-release formulation compared with diclofenac potassium: randomised, double-blind trial in acute low back pain. Clin. Drug Investig. 2006, 26 (5), 267–277.

    OpenUrlPubMed
13. 13.↵
    1. Jantharaprapap R.,
    2. Stagni G

    . Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int. J. Pharm. 2007, 343 (1–2), 26–33.

    OpenUrlPubMed
14. 14.↵
    1. Aqil M.,
    2. Ali A

    . Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterization. Eur. J. Pharm. Biopharm. 2002, 54 (2), 161–164.

    OpenUrlPubMed
15. 15.↵
    1. Pandit V.,
    2. Khanum A.,
    3. Bhaskaran S.,
    4. Banu V

    . Formulation and evaluation of transdermal films for the treatment of overactive bladder. Int. J. Pharm. Tech. Res. 2009, 1 (3), 799–804.

    OpenUrl
16. 16.↵
    1. Aulton M. E

    . Pharmaceutics: The science of dosage form design, 2nd ed.; Churchill Livingstone: New York, 2002; pp 487–495.
17. 17.↵
    1. Sumanta M. K.,
    2. Dube R.,
    3. Suresh B

    . Transdermal drug delivery system of a haloperidol to overcome self-induced extrapyramidal syndrome. Drug Dev. Ind. Pharm. 2003, 29 (4), 405–415.

    OpenUrlPubMed
18. 18.↵
    1. Gattani S. G.,
    2. Gaud R. S.,
    3. Chaturvedi S. C

    . Formulation and evaluation of transdermal films of chlorpheniramine maleate. Indian Drugs 2007, 44, 27–33.

    OpenUrl
19. 19.↵
    1. Bharkatia M.,
    2. Nema R. K.,
    3. Gupta G. D.,
    4. Gaud R. S

    . Designing and evaluation of propranolol hydrochloride transdermal patch. The Pharma Rev. 2005, 3, 113–116.

    OpenUrl
20. 20.↵
    1. Stoughton R. B.,
    2. Fritsch W

    . Influence of dimethyl sulfoxide on human percutaneous absorption. Drug Dev. Ind. Pharm. 2003, 29 (4), 405–407.

    OpenUrlPubMed
21. 21.↵
    1. Gupta P. S.,
    2. Jain S. K

    . Effective and controlled transdermal delivery of metoprololtratarate. Int. Jour. Pharm. Sci. 2005, 67 (3), 346–350.

    OpenUrl
22. 22.↵
    1. Kulkarni R. V.,
    2. Mutalik S.,
    3. Hiremath D

    . Effect of plasticizers on the permeability and mechanical properties of eudragit films for transdermal application. Int. Jour. Pharm. Sci. 2002, 64 (1), 28–31.

    OpenUrl
23. 23.↵
    1. Rao R. P.,
    2. Divan P. V

    . Influence of casting solvent on permeability of ethyl cellulose free films for transdermal use. East Pharma. 1997, 40, 135–137.

    OpenUrl
24. 24.↵
    1. Ramesh G. Y.,
    2. Vishnu V.,
    3. Kishan V.,
    4. Rao Y. M

    . Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Curr. Drug. Deliv. 2007, 4 (1), 69–76.

    OpenUrlPubMed
25. 25.↵
    1. Donbrow M.,
    2. Samuelov Y

    . Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J. Pharm. Pharmacol. 1980, 32 (7), 463–470.

    OpenUrlPubMed
26. 26.↵
    1. Wagner J. G

    . Interpretation of percent dissolved time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 58 (10), 1253–1257.

    OpenUrlPubMed
27. 27.↵
    1. Higuchi T

    . Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drug dispersed in solid matrices. J. Pharm. Sci. 1963, 52 (12), 1145–1149.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Singh S

    . Drug stability testing and shelf life determination according to international guidelines. Pharm. Tech. 1999, 23 (6), 68–88.

    OpenUrl
29. 29.↵
    1. Winter C. A.,
    2. Risley E. A.,
    3. Nuss C. W

    . Carrageen ininduced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 1962, 111, 544–547.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Baker A. K.,
    2. Hoffmann V. L. H.,
    3. Meert T. F

    . Dextromethorphan and ketamine potentiate the antinociceptive effects of μ- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol. Biochem. Behav. 2002, 74, 73–86.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Aher K. B.,
    2. Bhavar G. B.,
    3. Joshi H. P

    . Rapid RP-HPLC method for quantitative determination of lornoxicam in bulk and pharmaceutical formulations. Int. J. Chem. Tech. Res. 2011, 3 (3), 1220–1224.

    OpenUrl
32. 32.↵
    1. Draize J. H.,
    2. Woodward G.,
    3. Calvery H. O

    . Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 1944, 82, 377–379.

    OpenUrlFREE Full Text
33. 33.↵
    1. Mutalik S.,
    2. Udupa N

    . Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J. Pharm. Sci. 2004, 93 (6), 1577–1594.

    OpenUrlPubMed
34. 34.↵
    1. Korsmeyer R. W.,
    2. Gurny R.,
    3. Doelker E.,
    4. Buri P.,
    5. Peppas N. A

    . Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15 (1), 25–35.

    OpenUrlCrossRefWeb of Science
35. 35.↵
    1. Peppas N. A

    . Pharmaceutical analysis of Fickian and non-Fickian drug release from polymers. ActaHelv. 1985, 60, 110–111.

    OpenUrl
36. 36.↵
    1. Bodmeir R.,
    2. Paeratakul O

    . Drug release from laminated polymeric films prepared from aqueous latexes. J. Pharm. Sci. 1990, 79 (1), 32–36.

    OpenUrlCrossRefPubMedWeb of Science